Cancer that begins in the immune system cells. There are two basic subtypes of lymphomas: Hodgkin lymphoma, which is indicated by the presence of a cell type called Reed-Sternberg and non-Hodgkin lymphomas, which includes a large and diverse group of cancers of immune system cells. Non-Hodgkin lymphoma can be further divided into a cancer that has a slow (growing) course and those who have an aggressive course.
Facebook
Twitter
LinkedIn
WhatsApp
Hodgkin lymphoma
To check if our service suits your case
We need to talk
Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.
Article categories
קטגוריות המאמרים
Popular topics
Tags
ASCO 2025
ASCO 2026
Biological Drugs
Breakthrough Therapy Designation
Breast Cancer Research
Breast Oncology
Cancer Research
Cancer Treatment
CAR T treatments
CDK4/6 Inhibitors
centralny układ nerwowy
Chemotherapy
Clinical Trial Enrollment
Clinical Trials
EGFR MET inhibitor
Fulvestrant
Gedatolisib
Genetic Engineering Treatments
Genomic Testing
HNSCC
Immunotherapy
innowacyjne terapie onkologiczne
Keytruda
leczenie nowotworów mózgu
leki biologiczne
Medical Cannabis
nadzieja dla pacjentów
nowe leczenie raka
Oncology
onkologia zaawansowana
OrigAMI-4
Personalized Medicine
PFS
PIK3CA
Precision Medicine
Progression Free Survival
przerzuty do opon mózgowo-rdzeniowych
Rybrevant
Stage 4 Cancer
Stage IV Breast Cancer
Subcutaneous Injection
Targeted Drugs
Targeted Therapy
Trial-In Pharma
VIKTORIA-1
